CapForce Inc. (LON:0A8L)

Market Cap	50.60M +722,902,041.0%
Revenue (ttm)	22.87M +500.6%
Net Income	17.55M +106.4%
EPS	1.66 +42.6%
Shares Out	n/a
PE Ratio	2.88
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	130
Open	4.01
Previous Close	n/a
Day's Range	4.01 - 5.51
52-Week Range	0.00 - 32.50
Beta	-2,756.73
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 11, 2026

About CapForce

CapForce Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company offers Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It also provides laboratory services; and collaboration services, including funded software arrangements. In addition, the company offers listing sponsorship and consultancy services. CapForce Inc. was formerly known as OpGen, In...

• Industry: Security and Commodity Brokers, Dealers, Exchanges, and Services
• Founded: 2001
• Employees: 3
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0A8L

Financial Performance

In 2025, CapForce's revenue was $30.20 million, an increase of 481.20% compared to the previous year's $5.20 million. Earnings were $23.48 million, an increase of 106.75%.

Financial numbers in USD

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 12, 2026

Data Sources Report a data error